Lanvin Group Holdings Limited (LANV)
NYSE: LANV · Real-Time Price · USD
2.080
-0.120 (-5.45%)
At close: Sep 12, 2025, 4:00 PM EDT
2.080
0.00 (0.00%)
Pre-market: Sep 15, 2025, 7:18 AM EDT
Lanvin Group Employees
Lanvin Group Holdings had 2,406 employees as of December 31, 2024. The number of employees decreased by 231 or -8.76% compared to the previous year.
Employees
2,406
Change (1Y)
-231
Growth (1Y)
-8.76%
Revenue / Employee
$142,055
Profits / Employee
-$88,393
Market Cap
243.24M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,406 | -231 | -8.76% |
| Dec 31, 2023 | 2,637 | -850 | -24.38% |
| Dec 31, 2022 | 3,487 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amazon.com | 1,546,000 |
| The Home Depot | 470,100 |
| Toyota Motor | 383,853 |
| The TJX Companies | 364,000 |
| Lowe's Companies | 270,000 |
| McDonald's | 150,000 |
| Tesla | 125,665 |
| Alibaba Group Holding | 124,320 |
LANV News
- 16 days ago - Lanvin Group Holdings Limited (LANV) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Lanvin Group Reports H1 2025 Revenue of €133 Million Operational Discipline and Early Recovery Momentum Set Foundation for Growth in H2 - PRNewsWire
- 26 days ago - Lanvin Group to Report 2025 First Half Results on August 29, 2025 - PRNewsWire
- 4 months ago - Lanvin Group Holdings Limited (LANV) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Lanvin Group Demonstrates Strategic Resilience in Challenging Luxury Market, Lays Foundation for Future Growth - PRNewsWire
- 5 months ago - Lanvin Group to Report 2024 Full-Year Audited Results on April 30, 2025 - PRNewsWire
- 6 months ago - PharmaEssentia Highlights Availability of BESREMi® (ropeginterferon alfa-2b-njft) for Patients Affected by Pegasys® (peginterferon alfa-2a) Drug Shortage - Business Wire
- 7 months ago - Lanvin Group Holdings Limited (LANV) 2024 Sales/Trading Statement Call Transcript - Seeking Alpha